FDA to weigh easing limits on unproven peptides Is BPC 157 Banned? Oral vs. Injectable Forms Explained FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling RFK Jr. and the Perils of Peptides Washington Monthly The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and